APA (7th ed.) Citation

Tannen, R., Xie, D., Wang, X., Yu, M., & Weiner, M. G. (2013). A new "Comparative Effectiveness" assessment strategy using the THIN database: Comparison of the cardiac complications of pioglitazone and rosiglitazone. Pharmacoepidemiology and drug safety, 22(1), 86-97. https://doi.org/10.1002/pds.3360

Chicago Style (17th ed.) Citation

Tannen, Richard, Dawei Xie, Xingmei Wang, Menggang Yu, and Mark G. Weiner. "A New "Comparative Effectiveness" Assessment Strategy Using the THIN Database: Comparison of the Cardiac Complications of Pioglitazone and Rosiglitazone." Pharmacoepidemiology and Drug Safety 22, no. 1 (2013): 86-97. https://doi.org/10.1002/pds.3360.

MLA (9th ed.) Citation

Tannen, Richard, et al. "A New "Comparative Effectiveness" Assessment Strategy Using the THIN Database: Comparison of the Cardiac Complications of Pioglitazone and Rosiglitazone." Pharmacoepidemiology and Drug Safety, vol. 22, no. 1, 2013, pp. 86-97, https://doi.org/10.1002/pds.3360.